Part A: In Patients With Chronic Liver Diseases, LAENNEC (Human Placenta Hydrolysate) is to Assess Safety and Tolerability After the Doses of Doses. Part B: Part A, it is to Determine the Optimal Dose by Evaluating Two Capacity and Placebo Groups.

  • STATUS
    Recruiting
  • End date
    Jun 22, 2023
  • participants needed
    49
  • sponsor
    Green Cross Wellbeing
Updated on 7 October 2022

Summary

Part A: In Patients With Chronic Liver Diseases, LAENNEC (Human Placenta Hydrolysate) is to Assess Safety and Tolerability After the Doses of Doses.

Part B: Part A, it is to Determine the Optimal Dose by Evaluating Two Capacity and Placebo Groups.

Details
Condition Chronic Liver Disease
Treatment Normal saline, LAENNEC (Human Placenta Hydrolysate)
Clinical Study IdentifierNCT05532124
SponsorGreen Cross Wellbeing
Last Modified on7 October 2022

Eligibility

Yes No Not Sure

Inclusion Criteria

At the time of screening, 18 or 75 years
Those who have been diagnosed with alcoholic or non -alcoholic fatty liver disease and have persisted for more than 6 months
Those who are 1.5 times (60 IU/L) of the ALT level of Baseline (60 IU/L)
A person who can complete the signature agreement and compliance the requirements for clinical trials

Exclusion Criteria

Liver function abnormalities caused by the following cause disease: viral hepatitis, biliary obstructions, autoimmune hepatitis, wilson disease, hematoprive
Drug allergic symptoms (oscillation, heat, itching)
Those with systemic infection (including tuberculosis)
If the test person judges that it is difficult to participate in clinical trials due to the next disease: Cirrhosis of CHILD C or higher, cirrhosis with edema and plural, malignant tumors, severe disorders, severe renal disorders, severe cardiovascular disease, severe nerve Mental disorders, preferences, etc
Those who have experienced use of human -derived medicines within 6 months before selecting a test subject
Those who have received other clinical drugs within 3 months before selecting a test subject
Magnetic Resonance Spectroscopy (MRS) is impossible
A person who does not perform appropriate contraception as a pregnant woman, a nursing or a woman of childbearing age (effective contraception method: Barrier methods using infertility surgery, uterine device, condom, killer)
Those who cannot inject intravenous infusions
Those who judged that other testors were inappropriate as clinical trials
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Loading...

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note